Winfried März

Evaluation of the apo E genotyping kit on the LightCycler.

W. März, H. Wieland, M. Nauck, 2000, Clinical chemistry.

FH-Freiburg: a novel missense mutation (C317Y) in growth factor repeat A of the low density lipoprotein receptor gene in a German patient with homozygous familial hypercholesterolemia.

W. März, H. Scharnagl, M. Nauck, 2000, Atherosclerosis.

Lifibrol enhances the low density lipoprotein apolipoprotein B-100 turnover in patients with hypercholesterolemia and mixed hyperlipidemia.

W. März, H. Wieland, K Winkler, 1999, Atherosclerosis.

Detection of mutations in the apolipoprotein CII gene by denaturing gradient gel electrophoresis. Identification of the splice site variant apolipoprotein CII-Hamburg in a patient with severe hypertriglyceridemia.

W. März, C. Pullinger, H. Wieland, 1998, Clinical chemistry.

Therapy with recombinant human erythropoietin reduces cardiac size and improves heart function in chronic hemodialysis patients.

W. März, P. Grützmacher, M. Bergmann, 1991, American journal of nephrology.